At the University of Illinois at Urbana-Champaign, a team led by Han Lee integrates deep learning with Photonic Resonator Absorption Microscopy (PRAM) to create LOCA-PRAM. This system automatically identifies single biomarker molecules tagged with gold nanoparticles by analyzing red LED microscopy images and eliminating artifacts. By training the AI model with paired high-resolution SEM validation data, LOCA-PRAM delivers rapid, accurate molecular counts at the point of care for early disease diagnostics.

Key points

  • LOCA-PRAM uses context-aware deep neural network to identify gold-nanoparticle–tagged biomarkers in PRAM images.
  • Paired SEM imaging provides high-resolution ground truth for AI training, yielding >95% accuracy in nanoparticle localization.
  • System achieves single-molecule sensitivity below 0.1 pM concentration with false-positive rates reduced by over 50% in point-of-care tests.

Why it matters: LOCA-PRAM ushers in accessible single-molecule diagnostics, enabling rapid, accurate disease detection at the patient’s side without expert intervention.

Q&A

  • What is Photonic Resonator Absorption Microscopy?
  • Why integrate machine learning with biosensors?
  • How does SEM validation improve AI performance?
  • What advantages do gold nanoparticles offer in biosensing?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...


Read full article

Point-of-Care Biosensing Technologies in Longevity Science

Biosensing involves measuring biological markers in fluids like blood, saliva, or urine to track health and disease. In longevity science, identifying aging biomarkers can reveal changes in cellular function or metabolic pathways that signal accelerated aging or potential interventions. Point-of-care biosensors bring testing out of specialized laboratories and into clinics, pharmacies, or even homes, enabling regular monitoring and timely adjustments to lifestyle or therapies.

Key Components of Point-of-Care Biosensing
  • Aging Biomarkers: Molecules such as proteins, nucleic acids, or metabolites that correlate with biological age or age-related diseases.
  • Sensor Platforms: Devices leveraging optical, electrochemical, or mechanical detection methods to convert biomarker interactions into readable signals.
  • Nanoparticle Labels: Tiny particles (e.g., gold nanoparticles) attached to biomarkers to amplify detection signals.
  • Machine Learning: Algorithms that analyze complex sensor data to distinguish true signals from noise and quantify biomarker levels.
How Point-of-Care Biosensing Works
  1. Sample Collection: A small fluid sample is obtained via finger prick or swab.
  2. Labeling: Biomarkers bind to receptors on the sensor surface and are tagged with nanoparticles.
  3. Signal Acquisition: The sensor emits light or an electrical signal that interacts with the labeled biomarkers.
  4. Data Analysis: Embedded software or connected apps use machine learning to process signals, correct artifacts, and compute biomarker concentrations.

By integrating these elements, point-of-care biosensing enables frequent, minimally invasive monitoring of aging biomarkers such as inflammatory cytokines or telomere-associated proteins. Early detection of abnormal biomarker levels can prompt lifestyle modifications—like diet, exercise, or supplements—to slow biological aging processes. These technologies also support personalized medicine by tracking individual responses to anti-aging interventions over time.

Innovations such as AI-enhanced microscopy tools demonstrate how advanced sensing and computational methods can improve sensitivity and reliability. As point-of-care devices become more affordable and user-friendly, they hold promise for widespread access to longevity monitoring, empowering individuals to manage their health proactively and researchers to gather real-world data on aging interventions.

Machine Learning Advances Enable Diagnostic Testing Beyond the Lab